Radiopharm Theranostics Limited American Depositary Shares (RADX)
Stock · NASDAQ · Health Care
$1.05as of 10/16/2026
Price chart
Active signals
RADX Signal Track Record
How signals performed across all stocks →What RADX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume SpikeActive now | 10 | -7.6% | 30% | September 15, 2026 |
| Bollinger Band Breakdown | 5 | -5.8% | 40% | September 15, 2026 |
| 200-Day Moving Average TouchActive now | 5 | -4.5% | 0% | February 25, 2026 |
| Any 20-session window (baseline) | -5.9% | 25% |
Computed by MarketWall from daily closing prices since September 24, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About RADX
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs in the United States. The company develops RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeuti…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 14
- Website
- radiopharmtheranostics.com/
Fundamentals
- 1-day range
- $0.9001$1.14
- Market cap
- $40.11M
- P/E (trailing)
- —
- P/E (forward)
- -0.44
- EPS (trailing)
- $-0.02
- Dividend yield
- —
- Beta
- 0.08
- Avg. volume
- 88.9K
Forecasts
6 analyst ratings
Radiopharm Theranostics Limited American Depositary Shares Competitors
Chosen by industry and closest market cap.
- RADXRadiopharm Theranostics Limited American Depositary Shares$1.03▼ 4.63%Market cap $40.11MP/E —$0.0035$0.037
- HYPDHyperion DeFi Inc. Common Stock$2.84▼ 9.84%Market cap $40.47MP/E 7.24$2.34$9.13
- NSRXNasus Pharma Ltd. Ordinary Shares$3.18▲ 0.47%Market cap $39.70MP/E —$1.98$9.5
- PDSBPDS Biotechnology Corporation Common Stock$1.13▼ 13.08%Market cap $41.78MP/E —$0.1952$1.79
- APLMApollomics Inc. Class A Ordinary Shares$21.1▲ 0.48%Market cap $37.33MP/E —$10.01$42.12
- CRVOCervoMed Inc. Common Stock$2.24▼ 0.44%Market cap $37.33MP/E —$2.13$10
- IXHLIncannex Healthcare Inc. Common Stock$2.82▼ 2.08%Market cap $37.21MP/E —$2.49$14.91
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| RADX Radiopharm Theranostics Limited American Depositary Shares | $40.11M | — | $1.03 | ▼ 4.63% | $0.0035$0.037 |
| HYPD Hyperion DeFi Inc. Common Stock | $40.47M | 7.24 | $2.84 | ▼ 9.84% | $2.34$9.13 |
| NSRX Nasus Pharma Ltd. Ordinary Shares | $39.70M | — | $3.18 | ▲ 0.47% | $1.98$9.5 |
| PDSB PDS Biotechnology Corporation Common Stock | $41.78M | — | $1.13 | ▼ 13.08% | $0.1952$1.79 |
| APLM Apollomics Inc. Class A Ordinary Shares | $37.33M | — | $21.1 | ▲ 0.48% | $10.01$42.12 |
| CRVO CervoMed Inc. Common Stock | $37.33M | — | $2.24 | ▼ 0.44% | $2.13$10 |
| IXHL Incannex Healthcare Inc. Common Stock | $37.21M | — | $2.82 | ▼ 2.08% | $2.49$14.91 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 51.31M
- Total value held
- $2.06M
- Institutional holders
- 7
- Unknown51.00M
- Unknown187.4K
- Unknown61.4K
- Unknown40.1K
- Unknown16.0K
- Unknown3.0K
- Unknown121
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Edison releases report on Starpharma, not RADX
The available news covers a report on Starpharma (SPL), which is a different company. There is no specific news provided for Radiopharm Theranostics (RADX) in this update. The technical data shows the stock is near support, but without relevant news, no specific market event can be described for this symbol.
Edison releases report on Starpharma, not RADX. The available news covers a report on Starpharma (SPL), which is a different company. There is no specific news provided for Radiopharm Theranostics (RADX) in this update. The technical data shows the stock is near support, but without relevant news, no specific market event can be described for this symbol.